Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.31%
#2 aelf aelf +23.02%
#3 Venom Venom +14.28%
#4 Bitway Bitway +13.63%
#5 Pons Pons +10.65%
#6 Decred Decred +10.50%
#7 TRIA TRIA +9.66%
#8 Wibx Wibx +8.12%
#9 AtomOne AtomOne +7.63%
#10 DexNet DexNet +7.56%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Aelis Farma S.A. Aelis Farma S.A.

Aelis Farma S.A.

AELIS
Rankning i aktier #30384
Aelis Farma S.A., a French biotechnology company founded in 2013 and... Aelis Farma S.A., a French biotechnology company founded in 2013 and headquartered in Bordeaux, is dedicated to the discovery and development of treatments for brain-related illnesses. The firm's research pipeline primarily focuses on signaling-specific inhibitors that target CB1 receptors. Its leading investigational drug, AEF0117, is currently advancing through Phase 2b clinical trials, designed to alleviate the harmful impacts of excessive cannabis consumption. Furthermore, AEF0217, another key drug candidate, has successfully completed Phase 1 clinical trials, with the goal of addressing cognitive impairments linked to Down syndrome and other similar conditions.
Aktiekurs
$1.25
Senast synkroniserad: 2026-08-18
Marknadsvärde
$17.05M
Förändring (1 dag)
-1.50%
Förändring (1 år)
-22.24%
Land
FR
Handel Aelis Farma S.A. (AELIS)

Kategori

Healthcare
Aktiekurshistorik för Aelis Farma S.A. (AELIS)
Högsta slutkurs: $1.25 den 2026-08-01

Lägsta slutkurs: $14.72 den 2022-02-01
Aktiekurshistorik för Aelis Farma S.A. från 2022 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 10.37%
2025 -46.69%
2024 -83.48%
2023 20.47%
2022 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.89 35.09%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $996.61 51.72%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $115.74 -20.49%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $735.86 6.07%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $257.75 14.92%
BE